ExodusPoint Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Buy |
+25,313
| New | +$1.2M | 0.01% | 849 |
|
|
2024
Q4 | – | Sell |
-16,855
| Closed | -$850K | – | 1720 |
|
|
2024
Q3 | $850K | Buy |
+16,855
| New | +$850K | 0.01% | 955 |
|
|
2024
Q1 | – | Sell |
-28,417
| Closed | -$1.72M | – | 1666 |
|
|
2023
Q4 | $1.72M | Sell |
28,417
-16,764
| -37% | -$1.01M | 0.01% | 583 |
|
|
2023
Q3 | $2.58M | Buy |
+45,181
| New | +$2.58M | 0.02% | 564 |
|
|
2022
Q1 | – | Sell |
-25,200
| Closed | -$249K | – | 2426 |
|
|
2021
Q4 | $249K | Buy |
25,200
+200
| +0.8% | +$1.98K | ﹤0.01% | 1688 |
|
|
2021
Q3 | $247K | Hold |
25,000
| – | – | ﹤0.01% | 1649 |
|
|
2021
Q2 | $259K | Hold |
25,000
| – | – | ﹤0.01% | 1753 |
|
|
2021
Q1 | $255K | Sell |
25,000
-9,551
| -28% | -$97.4K | ﹤0.01% | 1714 |
|
|
2020
Q4 | $393K | Buy |
+34,551
| New | +$393K | ﹤0.01% | 1321 |
|